Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Standard Biotools Inc (LAB)

Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 630,687
  • Shares Outstanding, K 384,565
  • Annual Sales, $ 174,430 K
  • Annual Income, $ -138,890 K
  • EBIT $ -124 M
  • EBITDA $ -115 M
  • 60-Month Beta 1.26
  • Price/Sales 3.66
  • Price/Cash Flow N/A
  • Price/Book 1.44

Options Overview Details

View History
  • Implied Volatility 125.18% (+16.80%)
  • Historical Volatility 85.40%
  • IV Percentile 28%
  • IV Rank 16.32%
  • IV High 664.41% on 04/08/25
  • IV Low 20.04% on 09/04/25
  • Expected Move (DTE 29) 0.1700 (10.33%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 36
  • Volume Avg (30-Day) 67
  • Put/Call OI Ratio 0.34
  • Today's Open Interest 2,857
  • Open Int (30-Day) 3,059
  • Expected Range 1.4750 to 1.8150

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.05
  • Number of Estimates 1
  • High Estimate -0.05
  • Low Estimate -0.05
  • Prior Year -0.07
  • Growth Rate Est. (year over year) +28.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2300 +33.33%
on 12/31/25
1.6920 -3.07%
on 12/23/25
-0.0400 (-2.38%)
since 12/22/25
3-Month
1.0700 +53.27%
on 11/07/25
1.7200 -4.65%
on 12/22/25
+0.3200 (+24.24%)
since 10/22/25
52-Week
0.9200 +78.26%
on 05/23/25
1.8100 -9.39%
on 01/23/25
-0.1900 (-10.38%)
since 01/22/25

Most Recent Stories

More News
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2025 Revenue

BOSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (“Standard BioTools” or the “Company”) today announced preliminary and unaudited revenue results for the fourth...

LAB : 1.6400 (+0.30%)
Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass Cytometry

Advancing next-generation IMC workflows with class-leading HCR imaging technologies for greater sensitivity and flexibility

LAB : 1.6400 (+0.30%)
Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks

Following global commercial launch in September, Illumina Protein Prep's "out of the box" solution drives extraordinary accessibility to proteomics for researchers, with over 40,000 samples processed

ILMN : 154.06 (+1.04%)
LAB : 1.6400 (+0.30%)
Standard BioTools: Q3 Earnings Snapshot

Standard BioTools: Q3 Earnings Snapshot

LAB : 1.6400 (+0.30%)
Standard BioTools Reports Third Quarter 2025 Financial Results

SOUTH SAN FRANCISCO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company” or “Standard BioTools”) today announced financial results for the quarter ended...

LAB : 1.6400 (+0.30%)
Standard BioTools to Announce Third Quarter Financial Results on November 4, 2025

SOUTH SAN FRANCISCO, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced that it will publish third quarter 2025 financial results on Tuesday, November 4, 2025,...

LAB : 1.6400 (+0.30%)
TD Cowen Sticks to Its Hold Rating for Standard BioTools (LAB)

TD Cowen analyst Daniel Brennan maintained a Hold rating on Standard BioTools on October 10 and set a price target of $1.55. The company’s shares closed yesterday at $1.29.Elevate Your Investing Strategy:...

LAB : 1.6400 (+0.30%)
Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development

Illumina Protein Prep can measure 9500 unique human protein targets, offering new insights into protein biology to fuel novel discovery for treatment of disease

ILMN : 154.06 (+1.04%)
LAB : 1.6400 (+0.30%)
Standard BioTools: Q2 Earnings Snapshot

Standard BioTools: Q2 Earnings Snapshot

LAB : 1.6400 (+0.30%)
Standard BioTools Reports Second Quarter 2025 Financial Results

SOUTH SAN FRANCISCO, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company” or “Standard BioTools”) today announced financial results for the second quarter...

LAB : 1.6400 (+0.30%)

Business Summary

Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm...

See More

Key Turning Points

3rd Resistance Point 1.8433
2nd Resistance Point 1.7467
1st Resistance Point 1.6933
Last Price 1.6400
1st Support Level 1.5433
2nd Support Level 1.4467
3rd Support Level 1.3933

See More

52-Week High 1.8100
Last Price 1.6400
Fibonacci 61.8% 1.4700
Fibonacci 50% 1.3650
Fibonacci 38.2% 1.2600
52-Week Low 0.9200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar